Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dear Mettrum Client,
As part of our ongoing voluntary recall investigation and to further enhance our strict quality control, Mettrum has conducted additional testing on its products. As a result, Mettrum has recently become aware that some of its products contain small amounts of Myclobutanil, a pesticide not currently approved for use on cannabis under the Pest Control Products Act.
Rest assured, this material is not deemed to present a health risk. The fungicide Myclobutanil is used widely in Canada and around the world on food crops including lettuce, fresh fruit and berries.
Mettrum is committed to supplying the highest-quality and safest product to our clients at all times. In keeping with this commitment, and in full cooperation with Health Canada, Mettrum is extending its voluntary withdrawal of medical cannabis to include products that have been found to contain the substance. As a precautionary measure, Mettrum is also expanding the recall to include all products sold between January 1, 2016 and March 21, 2016. This is an extension to the process defined by Health Canada as a Type III recall: a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.
You are receiving this email because our records indicate that you may have received product that fits in the scope of this voluntary withdrawal. With your privacy and safety in mind, we encourage you to please login to Mettrum’s secure client portal here, for more specific information and next steps as to how to safely destroy any remaining product. We also invite you to contact us directly on our dedicated voluntary recall line at 1-866-661-2060 or by sending an email to inquiries@mettrum.com should you have any further questions.
We apologize for any inconvenience that this may cause and would like to extend a discount of 20% on your next purchase with Mettrum in appreciation of your cooperation and continued support.
Yours in good health,
Mettrum
https://news.lift.co/mettrum-expands-recall-to-all-products-sold-between-january-1-2016-and-march-21-2016/
"Tweed and Bedrocan customers have not been impacted and that all cannabis products purchased from Tweed and Bedrocan are safe to consume. They have been produced using the same Quality Assurance standards you've come to expect from our company and have been tested by third-party labs to verify levels of purity and cleanliness. "
I'm not sure what else your digging for. I'm a patient, I got an adequate response. Investors got a sufficient P.R. What else would you like?
Canopy Growth Addresses Mettrum Recall Issue
January 3, 2017 at 1:04 pm
https://www.newcannabisventures.com/canopy-growth-addresses-mettrum-recall-issue/
Published by NCV Newswire
Canopy Growth Corporation Comments on the Year that was 2016
SMITHS FALLS, ON, Jan. 3, 2017 /CNW/ – As a leader in Canada’s medical cannabis industry, Canopy Growth Corporation (Canopy Growth) (TSX: CGC) (OTC: TWMJF) wishes to offer the following commentary on the events of late 2016.
Transitioning Canadians into the legal cannabis system with the appropriate checks and balances has been very successful to date. The number of authorized medical cannabis users tripled in 2016 as healthcare professionals and individuals became increasingly aware of the emerging regulated system, and as the system itself evolved to better meet Canadians’ needs.
Since May 2014 when Tweed shipped its first gram, its facilities have evolved and become more efficient. Each stage of production and processing has dozens of Standard Operating Procedures that make its products better and safer. Through hard work and a culture of improving every aspect of our operations as we grow, Canopy Growth has earned almost a quarter of the market share and developed a strong track record of compliance across multiple facilities.
Canada is ahead of the global curve with regards to cannabis regulation. The system in place today has successfully introduced over one hundred thousand Canadians to a legal source of cannabis for medical purposes. The success of the Access to Cannabis for Medical Purposes Regulations is evident in its growth, which has continued at a rate of approximately ten percent per month for more than two straight years. Quality of product is improving across the sector, while average prices have come down. Patients now have cannabis oils and capsules to choose from, in addition to a variety of dried cannabis options.
Late last year, our sector was met with two announced product recalls and some related negative media coverage. These instances were of course unfortunate. As neither recall was related to Canopy Growth or its subsidiaries, Canopy is in no position to comment on the details related to the product recalls. One of the companies, however, is set to join the Canopy family and we remain proud of the reputation Mettrum has built for its quality products, customer support, and physician outreach.
It is important to note that recalls are not the sign of a system in disarray, rather they are signs that the system is working to protect Canadian patients. This is true of all regulated industries, from food production to medical production, but it is especially important in a sector such as the cannabis industry, which remains in its infancy and subject to incredible scrutiny.
All licensed producers are highly regulated, tracking every plant from seed to sale, testing product for release, and maintaining samples in case further testing is required. Additionally, and unique to our sector given the direct relationship we have with our patients, every licensed producer has procedures in place to contact every one of our clients if a recall or other customer notification needs to occur. Upon discovering anything warranting a recall, such as the presence of unapproved treatment products, a licensed producer will ensure that impacted customers are identified and advised of the recall and of any potential risks associated with product consumption. Furthermore, substantial testing and reviews of procedures will occur, to ensure that corrective actions are put in place and implemented.
In the case of Mettrum’s disclosed recall, it was concluded by Health Canada and external experts that the recall constituted a Type 3 Recall, defined by Health Canada as a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences. All patients who are potentially impacted are notified, corrective actions are put in place, and existing product and procedures re-tested and examined.
Looking to the future, there are no signs of things slowing down for our sector or our Company. In spite of the fact that illegal sources exist, Canadians requiring cannabis for medical purposes increasingly place their trust in a system that delivers high quality products and has safeguards in place to recognize and react in the rare cases when that standard is not met. We are not perfect, nor is the system in which we operate. There will be bumps along the road, but for a new sector we all have a lot to take pride in.
As we enter a new year that will undoubtedly see the topic of cannabis debated everywhere from the water cooler to the floor of the House of Commons, it is important that we recognize the successes of the current system, identify and address its shortcomings, and create a uniquely Canadian cannabis sector that can continue to improve the lives Canadians and ensure a safe, reliable, and regulated supply of cannabis products.
Here’s to Future Growth.
Hi ,
Thank you for your email. In light of recent cannabis recalls we want to assure you that Tweed and Bedrocan customers have not been impacted and that all cannabis products purchased from Tweed and Bedrocan are safe to consume. They have been produced using the same Quality Assurance standards you've come to expect from our company and have been tested by third-party labs to verify levels of purity and cleanliness.
You place your trust in us to provide clean and safe medical cannabis and we do not take lightly our obligation to meet those expectations on a continual basis.
Information on all cannabis recalls is available on the Health Canada website (http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/index-eng.php), including information on the most recent Type III recalls, which are defined as situations in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.
Your health and well-being continue to be our first priority and with this in mind, we will continue to offer high-quality cannabis using production standards that meet and exceed the requirements of the ACMPR.
Thank you,
Customer Care Representative
On page 28 of the PDF version:
No. 33.
By the Honourable Senator Carignan, P.C.:
December 14, 2016—Concerning the legalization of marijuana, since November 4, 2015:
1. Which groups, public organizations, individuals and governments asked to be consulted for each of the following departments: Health, Justice and Public Safety?
2. For each of the abovementioned departments, which groups, public organizations, individuals and governments were consulted?
3. What studies did the government commit
Lift
Lift – ?@liftcannabis
Canadian Senate to Discuss Cannabis Legalization on January 31 http://www.parl.gc.ca/Content/Sen/Chamber/421/OrderPaper/090op_2017-01-31-e.htm …
Canadian Senate to Discuss Cannabis Legalization on January 31 https://t.co/kSmfcgnivI
— Lift Events & Experiences (@lift_events) January 24, 2017
Yes. The interest, I believe, is in the GMP practices that Bedrocan Canada is privy to, and by default, Canopy.
GMP-status 'a major step' for medical marijuana recognition, Bedrocan
Image: iStock/ChrisGorgio
By Dan Stanton+ 26-Jan-2017
http://mobile.in-pharmatechnologist.com/Regulatory-Safety/Cannabis-grower-gains-EMA-GMP-status-for-Dutch-plants
The GMP certification of a Dutch cannabis production facility is a “major step” in bringing medicinal marijuana to the level of evidence based medicines, says Bedrocan.
Medicinal cannabis producer Bedrocan International announced this week that its facilities in The Netherlands have been found to be compliant with good manufacturing practice (GMP) standards, following an inspection from the Dutch Health Care Inspectorate.
The site is one of five facilities worldwide which produce marijuana for Bedrocan and its licensees, and the news it has been deemed to comply with GMP standards was described as “significant” by the firm.
“It’s in our mission and vision to bring medicinal cannabis to the level of an evidence based medicine. Being compliant to GMP-standards is one major step in this process,” a Bedrocan spokesperson told in-Pharmatechnologist.com.
The certification represents the first time GMP-status has been given to a site for focusing on cultivation, but with standardised medical cannabis grown indoors and controlled by qualified personnel and high tech equipment, the site fulfils regulatory requirements.
“The European Medicines Agency (EMA) states that GMP is ‘that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use,’ the firm said.
“This means – amongst others – having a clean and hygienic manufacturing area, clearly defined and controlled environmental conditions, validated processes, well-documented procedures and instructions, records of manufacture and appropriate measures in case of defaults or complaints.”
The accreditation covers three facilities in The Netherlands with a total production area of 120,000 sq ft which annually, the firm told us, produce around 5,000kg of cannabis.
The company also hopes its sites in Canada and the Czech Republic will become fully compliant within the next year.
The firm supplies the Dutch Office for Medicinal Cannabis, and some Dutch compound pharmacies in the Netherlands, but also has contracts with pharma companies which use marijuana as an API, including Axim Biotechnologies.
Axim has an ongoing Phase II trial in The Netherlands for its cannabinoid (CBD) and tetrahydrocannabinol (THC) as a possible treatment for multiple sclerosis. It has also begun recruiting for a 40-patient clinical trial for another cannabinoid chewing gum – CanChewPlus – as a potential treatment for irritable bowel syndrome.
The company said its facilities in Canada and the Czech Republic are expected to become fully EMA GMP compliant next year. Starrenburg said the next step for the company is to become fully FDA compliant, but that Bedrocan’s first priority is its Dutch facilities. The company did not give an expected deadline for FDA GMP compliance. Bedrocan’s medical cannabis is supplied to patients and researchers in the Netherlands, Germany, Finland, Israel, Italy, Macedonia, and Poland.
https://www.google.com/url?rct=j&sa=t&url=http://www.pharmtech.com/bedrocans-netherlands-facility-becomes-gmp-compliant-0&ct=ga&cd=CAEYACoUMTA2NzQ2OTUwMzgwNzc4NDkzODUyGWZhNWZlMjVlNjgwNWI5NmQ6Y2E6ZW46Q0E&usg=AFQjCNEGb6c2HoeGyVsCi0H9YbuH2CFUQA
https://www.google.com/url?rct=j&sa=t&url=https://www.perssupport.nl/persbericht/9b9b57de-bd82-4c24-859c-73b645509161/bedrocan-becomes-world-first-gmp-approved-medicinal-cannabis-producer&ct=ga&cd=CAEYBSoUMTA2NzQ2OTUwMzgwNzc4NDkzODUyGWZhNWZlMjVlNjgwNWI5NmQ6Y2E6ZW46Q0E&usg=AFQjCNFpQ8w6M8zxT0dObLavlXFdgMAwjg
At 100ml in a bottle, and a gram a day dosage, a bottle is good for 100 days for regular daily users.
Anyone using 1mil a day of Bedro oil or Tweed oil is doing good. Way better than smoking. Better for the pocket, better for the lungs, better for public consumption.
I just glad another saturated Ganjah Head can validate the fact that these oils are NO JOKE. SUPER High ish. Don't be a hero and think 10:1 means consuming 10 mil because it's the same as 1 Joint. Big mistake
I'm glad your sharing this. Awesome comes on here talking about Tweed oil is weak? Absolutely Not! 10:1 is very , very potent. It sneaks up on you when you least expect it , and stays for a while. For medical strength, there is way more value in oil than dry flowers. I'd bet not too many naysayers have actually used Tweed or Bedro oils. They recommend to start low and go slow for a very good reason. Respect is Due. The oil is un imaginably potent. 1 mil, the equivalent of 0.1 of a gram, or one good toke, can potentially get someone medicated or high for hours! I read your Christmas Day comments and I can relate. A newbie took 1mil of my Bedrocan oil 10:1 and their reaction was very similar to yours. Nearly uncontrollable.
10:1 is no joke. It feels more like 1:1 because of its potency and how stable all the cannabinoids are . 1 mil feels like a whole gram. 1 mil feels like a whole joint. * 1 mil is about quarter of a tea spoon for this who don't know.
“The future looks bright for Tweed and Canopy Growth’s operations in this facility,” continued Linton. “It might even be time to reopen the famous Visitor Centre and start training tour guides.”
Tweed’s production to triple with purchase of old Hershey's factory
http://m.insideottawavalley.com/news-story/7075009-tweed-s-production-to-triple-with-purchase-of-old-hershey-s-factory
The entire 472,000 sq. ft footprint could almost triple current production and processing capacity, making it by far the largest indoor cannabis production facility in Canada, and likely, the world. The 42-acre site could also house hundreds of thousands of square feet of additional production and processing space, either indoors or in greenhouse growing platforms.
Tweed has already transformed 168,000 sq. ft of licensed space into Canada’s most innovative cannabis production space. Twelve of 39 potential growing rooms are operational, with another 12 multi-level growing rooms under construction and nearing completion. A research and development area has been used to drive innovation with some of Canada’s leading researchers and universities. Oil extraction capabilities, a separate dealer’s licence area, an in-house quality assurance lab, and the industry’s only seed breeding area have all been added and brought online in the last three years.
Reefer Riches
http://www.cbc.ca/firsthand/m/episodes/reefer-riches
CBC - First Hand Documentary Episode ( featuring Tweed Marijuana Inc. )
iPad ordering. MBAs at their chi chi boutiques. B.Y.O.C. (Cannabis) New Year’s Eve Bash. Marijuana-infused “baked” clams. And lots of cash.
These are scenes from the “Green Rush” in Colorado, the first jurisdiction in North America to legalize recreational marijuana.
And it’s just the beginning of a trend that could spread to Canada.
After 40 years of debate, the smoke is clearing. Majorities in both Canada and the United States favor legalization. Canada and more than half of the U.S. states have legalized medicinal marijuana, and eight states are expected to join Colorado and Washington State and go all the way to outright legalization in the next two years. In Canada, the medical marijuana industry is poised to go with them.
Vote Cast FOR the Resolution.
Me as well
Last year CGC was on tsxv. Different filing dates for venture and non venture securities. 45 days after end of Q is a general expectation I believe
http://www.osc.gov.on.ca/en/Companies_filing-calendar_index.htm
February 14 is CGC Due Date for filing Q3(ending 12/31/16)
Hashing It Out
http://bit.ly/2i3UYmS Listen to this, shared from the CBC Radio App:
Hashing It Out
http://bit.ly/2i3UYmS Listen to this, shared from the CBC Radio App:
Hashing It Out
Happy New Year to my Canopy Family !!!
Happy New Year to my Canopy Family ??????
The stinking hypocrisy over pot finally ending: Neil Macdonald
http://www.cbc.ca/beta/news/opinion/marijuana-legalization-macdonald-1.3895377
A look at Canada's damaging history with marijuana and what legalization might bring
Neil Macdonald · Opinion Columnist · CBC News
December 14, 2016
My late father was born early enough to remember mail-order catalogues offering THC capsules to people who were having trouble sleeping or eating.
It worked, obviously. THC, or tetrahydrocannabinol, is the active ingredient in cannabis, and while the term "the munchies" didn't exist in rural Ontario during the first two decades of the 20th century, that's what the catalogues were selling. That, and a nice buzz.
Anyway, Dad said it was elderly people, farmers worn out by a life of hard labour, who used the capsules, and no one connected the drug to murder, insanity, death or the rape of white women by members of other races.
Then, in 1923, Canada lost its mind, bought the murder, rape and insanity thing, and criminalized cannabis, and for the next 93 years — to this very day — has persecuted heaven knows how many people, ruining lives, ending careers, denying comfort to the ill, and actually sending people to the horror of prison, all for something most smart people knew all along is a piddling, victimless act.
Lives ruined
Of course, most victims of this were young people, who are more easily caught than adults with private homes. Or minorities, because they're shaken down far more often by police.
And the stinking hypocrisy was that plenty of politicians, including prime ministers, and plenty of police, and plenty of judges had, at one time or another, smoked a joint themselves, but remained willing to continue wrecking other people's lives for doing the same thing.
Few had the courage to speak out.
Twenty years or so ago, doing a documentary on cannabis, I spoke to a man who, as a university law student in 1979, had persuaded the Joe Clark government to propose decriminalization in the speech from the throne. (When I asked Clark many years later what happened to that initiative, he answered: "Ronald Reagan happened.")
But would that former law student talk on the record? Umm, no. Because, you see, he'd become a Crown attorney, and although he assured me his views had not changed, the police wouldn't appreciate them.
I also called a judge (later to become a much more senior and famous judge) who, in her student days, had advocated for reform of marijuana laws. Would she speak? Please don't mention me, she said.
Ditto a federal public servant who'd once headed the National Organization for the Reform of Marijuana Laws (NORML) in 1979. He was just plain scared by 1993; he hung up on me.
I even approached former justice minister Kim Campbell, running for prime minister at the time, to ask if she'd ever smoked pot. Yes, she said haughtily, but if you understand the law, Mr. Macdonald, you'll know I never violated it, because I never possessed the drug. It was passed to me. (The Mounties instantly disagreed with her legal opinion.)
It was a variation on Bill Clinton's not inhaling. Ridiculous, almost cowardly. Or Barack Obama, who admitted cocaine use in a memoir, then oversaw national crackdowns on pot.
Which brings us to Justin Trudeau. Let's be clear here: He openly acknowledged having used cannabis, and decided not just to decriminalize it, but to outright legalize it.
Good for Justin Trudeau. That took guts. That's called courageous leadership.
Conservatives, of course, will screech about this, until they shut up and accept it, the way they've given up fighting gay marriage.
But the weird thing is that legalization of marijuana is, strictly speaking, a conservative idea. Conservatives are, or are supposed to be, laissez-faire.
It's liberals who desperately want to use government to protect people from themselves.
Disclosure here: I enthusiastically smoked cannabis for years, until I stopped. It weirds me out now, and I can't handle it. It never made me want to try heroin, though, or rape anybody, or steal to get my pot fix. I am 100 per cent sure alcohol and tobacco, the single most preventable cause of cancer, did me far more damage. Let the government outlaw tobacco if it's so concerned about public health.
Big money
We are still in bizzaro world, by the way. We're supposed to be so much more progressive than the Americans, and yet hundreds of millions of Americans live in states where possession of cannabis is completely legal, or an offence that merits nothing more than a traffic ticket. At the same time, the Americans will bar a Canadian from the U.S. for life for admitting ever having smoked dope, and may continue to do so, especially under their bizarro-world new president.
And don't forget, there's a hell of a lot of money at stake here. Police, who have for decades inflated their budgets by busting kids for pot during the "war on drugs," are no doubt having urgent discussions with their political masters about keeping those budgets intact.
And of course other public servants are licking their chops at the prospect of enlarging their departments.
The Liquor Control Board of Ontario is already waving its hand around anxiously. The recommendation of the federal task force that marijuana be sold in a separate facility from alcohol is even better; new LCBOs (MCBOs?) can be built, and all sorts more staff hired, thereby grossly inflating the price of a joint. It's the Canadian way.
No doubt some LCBO executives are already planning glossy monthly magazines suggesting pairings of Thai-stick or Maui Wowee with a nice leg of lamb or a risotto. The governments that sent people to prison for pot will be promoting it. Shamelessness always pays.
You can bet a month's pay that conservative corporate Canada is already planning to elbow aside the funky little shops selling things like "purple kush" and the "edibles" bakeries, the sort that operate in Colorado and Washington. We don't want to be having too much fun.
Here's something else you can count on: tax, and lots of it. This week's task force recommendations even proposed taxing more potent pot more heavily. For everyone's safety, of course.
Nothing ever really changes.
Oh, and one other thing: once legalization happens, anybody with a marijuana-related criminal record should be pardoned.
Globe editorial: Marijuana legalization report wants people to have their pot and not smoke it, too
When the Trudeau government vowed to legalize the consumption of marijuana, there may have been those who believed the process would be straightforward. The final report of the Task Force on Cannabis Legalization and Regulation proves it will be anything but.
http://www.theglobeandmail.com/opinion/editorials/marijuana-legalization-report-wants-people-to-have-their-pot-and-not-smoke-it-too/article33316378/?arc404=true
Here are just a few samples of the task force’s slightly hallucinogenic recommendations:
http://www.theglobeandmail.com/opinion/editorials/marijuana-legalization-report-wants-people-to-have-their-pot-and-not-smoke-it-too/article33316378/?arc404=true
Don't hold your breath: fully legalized pot could still be years away
Legalizing pot is just the 1st step before the more complex task of regulating its use and sale
http://www.cbc.ca/beta/news/politics/cannabis-pot-weed-legal-1.3894284
Legislation to make pot legal will hit the House of Commons come spring, but the day when recreational marijuana becomes officially available to buy across the country could still be years away.
"I think one of the things we were struck by was how complex this transition actually is, and not only in terms of drafting legislation at the federal and provincial levels and putting in place all the infrastructure and training, but the psychological transition," former deputy prime minister Anne McLellan told CBC News Network's Power & Politics host Rosemary Barton.
"Going from something that has been prohibited for decades, to a world where it's a legalized product, sold in a regulated market — so the transition is going to be enormous," said McLellan, the chair of the federal government's cannabis task force.
The Department of Justice Canada will first have to embark on a widespread effort to change the Criminal Code and other related federal laws — that effort will kick off in the spring. But what that new law will look like and what kinds of challenges it will face as it moves through Parliament remain a mystery for now.
"This is just the task force report. I mean, obviously it should be influential, but the government could go in a different direction," said Eugene Oscapella, professor of law at the University of Ottawa.
That was certainly the case with the federal government's assisted-dying law. A Commons-Senate committee report tabled in advance of the assisted-dying law called for a much more permissive bill than the Liberal government introduced and passed.
Many are wondering if that could be the case again this time.
"They are going to introduce a bill. Who knows if it's going to buy the recommendations in this report. Please remember it's just recommendations. They might say, 'We like some, we don't like others.' A lot of them are in provincial jurisdiction anyway," said NDP MP Murray Rankin.
Oscapella said the federal government needs to start by sitting down and deciding exactly what parts of the legalization regime will fall under federal jurisdiction and what parts will be provincial.
'A huge practical problem'
Once the federal laws have been changed, Health Canada will have to design a regulatory system for weed, and all this has to happen before the provinces and municipalities figure out how to build a distribution and enforcement system.
"The capacity required to regulate the size of this new market — that is just a huge practical problem that is going to have to be overcome," said Neil Boyd, author of High Society, Legal and Illegal Drugs in Canada and professor of law in the School of Criminology at Simon Fraser University.
Boyd notes that the two main purposes of the move to end cannabis prohibition were to take the market away from organized crime and to keep the drug out of the hands of young people.
But if one province, for example, restricts the sale of weed to a mail order service, while a neighbouring province has a network of retail shops selling the drug, would people start moving it across borders, and if they did, would that be illegal? Or would it simply keep the illegal market open?
Who polices what?
Another concern Boyd raises is the costs of regulation. If regulation increases the price of marijuana well above the current black market price, would cutting out criminals still be possible?
Oscapella said it's one thing to make cannabis legal, but policing the regulations is a separate question. If someone is operating outside those new laws, are they committing a criminal offence, or a regulatory infraction?
If police have reason to believe a person is growing five plants instead of four, as recommended in the task force's report, would police have the same search and seizure powers they do now, or will those have to be changed as well?
These are questions Canada's police forces will want to have answered.
"There has to be a balance between accessibility and control because one objective that we have … is to address the organized crime, to make sure that we can take them away from the distribution and the point of sale as much as possible," said Mario Harel, president of the Canadian Association of Chiefs of Police.
"This balance of accessibility and being able to grow, or to be in possession, I think it's a delicate balance that the government has to address in their future bill," he added.
A long road ahead
Rankin said the parliamentary process, let alone the regulatory one, could take a long time to complete.
"You bring a bill in, it goes to committee, three readings … House and Senate. When will we have law? And when will they proclaim the law? It could be years from now," he said.
Liberal MP Bill Blair, parliamentary secretary to the minister of justice and the government's point man on pot legalization, concedes the effort will take time.
"The only precise time frame that we've committed to, is our minister of health has said she will bring legislation forward in the spring of 2017," Blair said.
"We know we've got a great deal of work to do to pass that legislation and even more work to put the regulatory framework and all of the infrastructure that will be necessary in order to do this right, and I will tell you; we are committed to taking the time to do it right."
Statement from the Government of Canada on the Receipt of the Report from the Task Force on Cannabis Legalization and Regulation
http://news.gc.ca/web/article-en.do?utm_source=twitter_hc&utm_medium=social_en&utm_content=mj_task_force9&utm_campaign=mj_task_force_16&nid=1168809
December 13, 2016 (Ottawa, ON) – The Minister of Public Safety and Emergency Preparedness, the Minister of Justice and Attorney General of Canada, the Minister of Health, and the Parliamentary Secretary to the Minister of Justice and Attorney General of Canada today announced that they have received the report from the Task Force on Cannabis Legalization and Regulation. They released the following statement:
“We are pleased to receive the report from the Task Force on Cannabis Legalization and Regulation. We would like to take this opportunity to sincerely thank the Honourable Anne McLellan and Dr. Mark Ware for their passionate and thoughtful leadership on this complex issue. We also wish to thank all of the members of the Task Force for generously dedicating their time and energy, and for all of their hard work over the last five months. We echo the Task Force’s appreciation for the interest and enthusiasm shown by Canadians in this process. There will be several opportunities to consult Canadians as the government proceeds to legalize, and strictly regulate, cannabis.
We look forward to continuing to work closely and collaboratively with the provinces and territories and with our partners and stakeholders.
We appointed the Task Force in June to provide its best advice on how to legalize and strictly regulate cannabis to keep it out of the hands of youth and profits out of the hands of criminals. The delivery of the Task Force report is an important step in helping the Government fulfil its commitment to legalize, strictly regulate and restrict access to cannabis. We will be carefully considering the Task Force’s advice as we develop legislation to be introduced in Parliament in the spring of 2017. The new legislation would come into force after being passed by Parliament and once regulations have been developed.
Until the new legislation comes into force, the current cannabis laws remain in effect. For information on current laws, please consult the Ministers’ joint statement from June 30, 2016.”
The Honourable Ralph Goodale, Minister of Public Safety and Emergency Preparedness
The Honourable Jody Wilson-Raybould, Minister of Justice and Attorney General of Canada
The Honourable Dr. Jane Philpott, Minister of Health
Bill Blair, Parliamentary Secretary to the Minister of Justice and Attorney General of Canada.
The Task Force received nearly 30 000 responses to their online questionnaire, and organizations sent nearly 300 submissions. The Task Force met with representatives of provincial, territorial and municipal governments and experts from a wide spectrum of disciplines including researchers and academics; patients and their advocates; cannabis consumers; chiefs of police and fire departments; as well as numerous industry, professional, health and other associations. Indigenous experts, representative organizations, governments and elders were invited to participate in a variety of Task Force engagement activities, including the expert roundtables, bilateral meetings and an Indigenous people's roundtable.
Mr. Bruce Linton reports
CANOPY GROWTH STATEMENT ON CANNABIS TASK FORCE REPORT
http://www.stockwatch.com/News/Item.aspx?bid=Z-C:CGC-2430217&symbol=CGC®ion=C
After a preliminary review of the findings of the special task force which, on Dec. 13, 2016, released recommendations on the regulation of recreational cannabis, Bruce Linton, chairman and chief executive officer of Canopy Growth Corp., wishes to issue the following statement:
"This report is good news for Canadians and, in our view, provides a strong policy framework for the government to consider. Most importantly, we think it confirms that the current medical system for production is working and should form the backbone of ongoing production into the future. It recognizes the value of limited grow-at-home and diversity of producers and access methods, all things we support as a company. It also recognizes that the existing mail-order system has merit as an ongoing complementary distribution system reaching all Canadians conveniently and securely.
"We have concerns that the task force is recommending no differentiated tax regime for medical and recreational sales, which has the potential to unduly burden cannabis patients. A path forward to insurance coverage must also remain a top priority for Canadian policymakers. Cannabis access can only truly be achieved if barriers to affordability are removed.
"On branding, we certainly agree with the need to limit promotion of cannabis, particularly anything that promotes the product to children or encourages irresponsible consumption. In our view, however, cannabis is not the same as tobacco or alcohol and merits its own carefully considered framework. Packaging debates are driven by public health concerns and rules surrounding packaging and promotion need to be balanced against cannabis's unique existence in the black market and the relative harms it presents to society and youth.
"Lastly, on the topic of corporate cannabis, we are proud of the hundreds of jobs we have created, the millions of dollars we have spent in Canadian communities building world-class production facilities, the thousands of doctors and researchers we have visited, the tens of thousands of patients we serve, and that we are building an innovative global cannabis company based right here in Canada. Our investments result in improved support, variety and quality for Canadian customers, and we are proud to always seek to advance the dialogue on cannabis policy. We are privileged to be a part of this exciting change, and look forward to expanding on our contributions in this sector over the months and years to come.
"Many details still need to be worked through, but this appears to be a very promising start to a successful Canadian policy framework, and we are thankful to the task force for their hard work in bringing concise policy recommendations forward on a very complex issue."
© 2016 Canjex Publishing Ltd. All rights reserved.
Highlights from the federal marijuana task force report
Panel makes over 80 recommendations to advise Liberal government in its legalization push
http://www.cbc.ca/beta/news/politics/marijuana-task-force-highlights-1.3894219
The task force Justin Trudeau's Liberal government appointed to study how marijuana could be legalized and regulated in Canada released its report Tuesday, offering over 80 recommendations.
Here are some highlights from the report:
Sales and marketing
Set the minimum age of purchase as 18, respecting the rights of provinces and territories to harmonize with sales of alcohol.
Avoid selling alcohol and cannabis at the same location where possible: dedicated storefronts and direct mail are preferable.
Limit the density and location of storefronts, including their proximity to schools and parks.
Regulate retail sales at the provincial and territorial level.
Restrict the promotion and advertising of cannabis products, similar to restrictions now in place for tobacco.
Require plain packaging with company name, strain name, price, tetrahydrocannabinol (THC) and cannabidiol (CBD) amounts and health warnings.
Prohibit any product deemed "appealing to children," including products that look like candy.
Anne McLellan on CBC Radio discussing The Task Force Report on As It Happens.
Fall of Aleppo, marijuana report, baby doll maker (Part 1 ):
http://bit.ly/2hrzXCs Listen to this, shared from the CBC Radio App:
Fall of Aleppo, marijuana report, baby doll maker (Part 1)
I think, the bottle neck is in the batch processing and quality assurance processes with health canada. They've spoken about it in conferences. Seed to sale , including regulations for Croptober. The "Crop" can only be released in series tested lots. So even if 15thousand kg are being harvested, it's not in a big grain silo. It's tree by tree. Bud by bud. Albeit, I do agree there is a sort of supply issue, somewhere in the chain.
In writing. On the wall
Gov anticipates a report from DDC commission on Drug impaired driving in " the coming months.
Timeline is up to GOV of Canada.
Dr Marc Ware en francais
Recommend maintaining the current ACMPR
It's live now
These are recommendations, remember. The Government is not obligated to anything in the report. But, I do think the Liberal Government will stay very close to what is in there overwhelmingly.
Wow. Just saw that. Aug 2015, 5500 patients. A year later 4x. Bruce was talking about what happens when 100k are registered. Not to far long. Not too far long
I noticed the author didn't mention what Tweed produced once, unlike Omya, and what's up with this
" Next week the company’s shareholders will vote on the acquisition. The deal will bring Tweed Inc.’s total client base to 5,500 individuals."
?
Ny way, it is a great follow up. Just seems the stigma is still hard to shake for this industry. Just getting full, details coverage seems to be a challenge
This , I believe is the discussion paper that precluded the Task Force , and not the final report.